MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Levodopa(L-dopa)"

  • 2019 International Congress

    Changes in close relationships among patients with Parkinson’s disease and their partners following initiation of device-aided treatment

    J. Timpka, M. Scharfenort, T. Sahlström, V. Hernström, T. Henriksen, D. Nyholm, P. Odin (Lund, Sweden)

    Objective: Our primary objective was to study whether there is a difference in how close relationships are perceived by Parkinson’s disease (PD) patients with device-aided…
  • 2019 International Congress

    Patients Experiencing Motor Fluctuations With Parkinson’s Disease (PD): Participant Characteristics in the Accordance Phase 3 Efficacy and Safety Trial of Accordion Pill™ Carbidopa/Levodopa

    P. Lewitt, R. Gendreau, J. Meckler, A. Hotovely-Salomon, N. Navon (West Bloomfield, MI, USA)

    Objective: To provide baseline and clinical characteristics for participants in the phase 3 Accordance study of the Accordion Pill™ (AP)—a gastric-retentive formulation of carbidopa/levodopa (CD/LD)—versus…
  • 2019 International Congress

    Toning down SPNs to improve motor responses to dopaminergic stimulation in Parkinson’s disease

    G. Beck, H. Mochizuki, S. Papa (Atlanta, GA, USA)

    Objective: This study was aimed at examining whether decreasing the baseline SPN firing frequency towards the low activity found in normal conditions reduces LID. Background:…
  • 2019 International Congress

    Are there associations between altered brain connectivity and dopaminergic medication in Parkinson’s disease patients with freezing of gait?

    A. Potvin-Desrochers, A. Atri, C. Paquette (Montreal, QC, Canada)

    Objective: The purpose of this study is to assess how brain connectivity is altered in Parkinson’s disease (PD) patients with freezing of gait (FOG), and…
  • 2019 International Congress

    Long-term impact of Levodopa Carbidopa Intestinal Gel (LCIG) on reducing “Off” time: Results from a systematic review of studies with ≥ 12 months of follow-up

    A. Antonini, P. Odin, R. Pahwa, J. Aldred, A. Alobaidi, Y. Jalundhwala, P. Kukreja, L. Bergmann, S. Inguva, Y. Bao, K. Chaudhuri (North Chicago, IL, USA)

    Objective: The objective of this study was to summarize evidence evaluating long-term (i.e. ≥ 12 months)efficacy of levodopa carbidopa intestinal gel (LCIG) on “off” time,…
  • 2019 International Congress

    Evaluating the real-world impact of levodopa/carbidopa intestinal gel (LCIG) on motor symptoms using wearable sensors: Evidence from PROviDE study

    R. Pahwa, R. Dorsey, S. Isaacson, P. Kandukuri, Y. Jalundhwala, P. Kukreja, N. Gupta, I. Pan, Y. Bao, D. Heldman (Kansas City, KS, USA)

    Objective: To objectively evaluate the real-world impact of carbidopa/levodopa enteral suspension (CLES) on motor symptoms in patients with advanced Parkinson’s disease (PD) in USA. Background:…
  • 2019 International Congress

    Stigma and Quality of life in Parkinson’s disease patients on different treatment regimens

    O. Vanta, L. Perju-Dumbrava, L. Perju-Dumbrava (Cluj-Napoca, Romania)

    Objective: To assess self reported quality of life (QOL) in patients with Parkinson’s disease (PD) under different treatment options and to evaluate the emotional burden…
  • 2019 International Congress

    Effects of levodopa on LTP-like plasticity induced by quadripulse magnetic stimulation in Parkinson’s disease

    S. Moriyasu, T. Shimizu, T. Honda, Y. Ugawa, R. Hanajima (Yonago, Japan)

    Objective: To study LTP-like effect induced by QPS on primary motor cortex of PD patients in “on” or “off” medication state and reveal the relationship…
  • 2019 International Congress

    An unusual cause of rhabdomyolysis in the patients with Parkinson’s disease: A report of two cases

    J. Srikajon, P. Srivanitchapoom, Y. Pitakpatapee, T. Sangpeamsook, C. Satukijchai, A. Suengtaworn (Bangkok, Thailand)

    Objective: To describe unusual cause of rhabdomyolysis in the two patients with Parkinson’s disease (PD). Background: Levodopa-induced dyskinesia (LID) is usually seen in advanced stage…
  • 2019 International Congress

    Long-term levodopa-carbidopa intestinal infusion in Parkinson’s disease: survival and mortality

    CA. Artusi, R. Balestrino, G. Imbalzano, S. Bortolani, S. Tuttobene, E. Montanaro, M. Zibetti, L. Lopiano (Torino, Italy)

    Objective: We sought to analyze the mortality and the causes of death of 105 patients with Parkinson disease (PD) treated with levodopa-carbidopa intestinal gel (LCIG)…
  • « Previous Page
  • 1
  • …
  • 45
  • 46
  • 47
  • 48
  • 49
  • …
  • 70
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley